Durable coexistence of donor and recipient strains after fecal microbiota transplantation
- PMID: 27126044
- DOI: 10.1126/science.aad8852
Durable coexistence of donor and recipient strains after fecal microbiota transplantation
Abstract
Fecal microbiota transplantation (FMT) has shown efficacy in treating recurrent Clostridium difficile infection and is increasingly being applied to other gastrointestinal disorders, yet the fate of native and introduced microbial strains remains largely unknown. To quantify the extent of donor microbiota colonization, we monitored strain populations in fecal samples from a recent FMT study on metabolic syndrome patients using single-nucleotide variants in metagenomes. We found extensive coexistence of donor and recipient strains, persisting 3 months after treatment. Colonization success was greater for conspecific strains than for new species, the latter falling within fluctuation levels observed in healthy individuals over a similar time frame. Furthermore, same-donor recipients displayed varying degrees of microbiota transfer, indicating individual patterns of microbiome resistance and donor-recipient compatibilities.
Copyright © 2016, American Association for the Advancement of Science.
Comment in
-
Gut microbiota: FMT - enduring strains.Nat Rev Gastroenterol Hepatol. 2016 Jul;13(7):376. doi: 10.1038/nrgastro.2016.84. Epub 2016 May 18. Nat Rev Gastroenterol Hepatol. 2016. PMID: 27188820 No abstract available.
Similar articles
-
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.PLoS One. 2018 Jan 31;13(1):e0190997. doi: 10.1371/journal.pone.0190997. eCollection 2018. PLoS One. 2018. PMID: 29385143 Free PMC article.
-
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.Microbiome. 2018 Sep 18;6(1):166. doi: 10.1186/s40168-018-0549-6. Microbiome. 2018. PMID: 30227892 Free PMC article.
-
Colonization potential to reconstitute a microbe community in patients detected early after fecal microbe transplant for recurrent C. difficile.BMC Microbiol. 2016 Jan 13;16:5. doi: 10.1186/s12866-015-0622-2. BMC Microbiol. 2016. PMID: 26758906 Free PMC article. Clinical Trial.
-
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.J Clin Microbiol. 2017 Apr;55(4):1002-1010. doi: 10.1128/JCM.02327-16. Epub 2017 Jan 11. J Clin Microbiol. 2017. PMID: 28077694 Free PMC article. Review.
-
[Fecal microbiota transplantation].Internist (Berl). 2017 May;58(5):456-468. doi: 10.1007/s00108-017-0203-6. Internist (Berl). 2017. PMID: 28235986 Review. German.
Cited by
-
Current perspectives on fecal microbiota transplantation in inflammatory bowel disease.Indian J Gastroenterol. 2024 Feb;43(1):129-144. doi: 10.1007/s12664-023-01516-8. Epub 2024 Feb 9. Indian J Gastroenterol. 2024. PMID: 38334893 Review.
-
The function of the gut microbiota-bile acid-TGR5 axis in diarrhea-predominant irritable bowel syndrome.mSystems. 2024 Mar 19;9(3):e0129923. doi: 10.1128/msystems.01299-23. Epub 2024 Feb 8. mSystems. 2024. PMID: 38329942 Free PMC article.
-
Microbiota and mucosal gene expression of fecal microbiota transplantation or placebo treated patients with chronic pouchitis.Gut Microbes. 2024 Jan-Dec;16(1):2295445. doi: 10.1080/19490976.2023.2295445. Epub 2024 Jan 12. Gut Microbes. 2024. PMID: 38214604 Free PMC article.
-
Microbiome as a biomarker and therapeutic target in pancreatic cancer.BMC Microbiol. 2024 Jan 5;24(1):16. doi: 10.1186/s12866-023-03166-4. BMC Microbiol. 2024. PMID: 38183010 Free PMC article. Review.
-
A tiny fraction of all species forms most of nature: Rarity as a sticky state.Proc Natl Acad Sci U S A. 2024 Jan 9;121(2):e2221791120. doi: 10.1073/pnas.2221791120. Epub 2024 Jan 2. Proc Natl Acad Sci U S A. 2024. PMID: 38165929
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
